Page last updated: 2024-08-21

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Hypoxia

2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with Hypoxia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haass, M; Hock, M; Richardt, G; Schömig, A1

Other Studies

1 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and Hypoxia

ArticleYear
Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
    Naunyn-Schmiedeberg's archives of pharmacology, 1989, Volume: 340, Issue:5

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Calcium; Chromatography, High Pressure Liquid; Electric Stimulation; Exocytosis; Ganglia, Sympathetic; Guinea Pigs; Hypoxia; Methoxyhydroxyphenylglycol; Myocardium; Neuropeptide Y; Norepinephrine; Radioimmunoassay; Tyramine; Veratridine

1989